(Circulation. 2005;112:2716-2724.)
© 2005 American Heart Association, Inc.
Vascular Medicine |
From the Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia (R.D.R., D.R., T.G., A.-M.C., T.S.P., G.A.F.); the Phenomix Corporation, La Jolla, Calif (P.M.); the Salk Institute for Biological Studies, La Jolla, Calif (S.P.); and Scripps Florida, Jupiter, Fla (J.B.H.).
Correspondence to Garret A. FitzGerald, MD, The Institute for Translational Medicine and Therapeutics, 153 Johnson Pavilion, University of Pennsylvania, 3620 Hamilton Walk, Philadelphia, PA 19104. E-mail garret{at}spirit.gcrc.upenn.edu
Received February 9, 2005; de novo received June 13, 2005; revision received August 1, 2005; accepted August 3, 2005.
Background Circadian rhythmicity of many aspects of cardiovascular functionblood pressure, coagulation and contractile functionis well established, as is diurnal variation in important clinical events, such as myocardial infarction and stroke. Here, we undertake studies to globally assess circadian gene expression in murine aorta.
Methods and Results Aortae from mice were harvested at 4-hour intervals for 2 circadian cycles (48 hours). Gene expression was assessed by expression profiling and subjected to a gene ontology bioinformatics analysis. Three hundred thirty transcripts exhibited a circadian pattern of oscillation in mouse aorta, including those intrinsic to the function of the molecular clock. In addition, many genes relevant to protein folding, protein degradation, glucose and lipid metabolism, adipocyte maturation, vascular integrity, and the response to injury are also included in this subset of roughly 7000 genes screened for circadian oscillation.
Conclusions Detection of functional cassettes of vascular genes that exhibit circadian regulation in the mouse will facilitate elucidation of the mechanisms by which the molecular clock may interact with environmental variables to modulate cardiovascular function and the response to therapeutic interventions.
This article has been cited by other articles:
![]() |
E. J. Westgate, Y. Cheng, D. F. Reilly, T. S. Price, J. A. Walisser, C. A. Bradfield, and G. A. FitzGerald Genetic Components of the Circadian Clock Regulate Thrombogenesis In Vivo Circulation, April 22, 2008; 117(16): 2087 - 2095. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-C. Liu, W.-J. Lin, E. Kim, L. L. Collins, H.-Y. Lin, I-C. Yu, J. D. Sparks, L.-M. Chen, Y.-F. Lee, and C. Chang Loss of TR4 Orphan Nuclear Receptor Reduces Phosphoenolpyruvate Carboxykinase Mediated Gluconeogenesis Diabetes, December 1, 2007; 56(12): 2901 - 2909. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Takeda, K. Maemura, S. Horie, K. Oishi, Y. Imai, T. Harada, T. Saito, T. Shiga, E. Amiya, I. Manabe, et al. Thrombomodulin Is a Clock-controlled Gene in Vascular Endothelial Cells J. Biol. Chem., November 9, 2007; 282(45): 32561 - 32567. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Martino, N. Tata, G. A. Bjarnason, M. Straume, and M. J. Sole Diurnal protein expression in blood revealed by high throughput mass spectrometry proteomics and implications for translational medicine and body time of day Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1430 - R1437. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Reilly, E. J. Westgate, and G. A. FitzGerald Peripheral Circadian Clocks in the Vasculature Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1694 - 1705. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |